Fol. Biol. 2012, 58, 203-208
https://doi.org/10.14712/fb2012058050203
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
References
1. 2008) ApoE genotype: impact on health, fitness and nutrition. World Rev. Nutr. Diet. 98, 77-93.
< , T. J., Lowndes, J. (https://doi.org/10.1159/000152923>
2. 2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220, 449-455.
< , A., Kamide, K., Oguro, R., Yasuda, O., Miyata, K., Yamamoto, E., Kawai, T., Kusunoki, H., Yamamoto, H., Takeya, Y., Yamamoto, K., Onishi, M., Sugimoto, K., Katsuya, T., Awata, N., Ikebe, K., Gondo, Y., Oike, Y., Ohishi, M., Rakugi, H. (https://doi.org/10.1016/j.atherosclerosis.2011.11.017>
3. 1994) Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Ann. Biochem. 222, 389-395.
< , I. N., Humphries, S. E. (https://doi.org/10.1006/abio.1994.1507>
4. 2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 41, 280-282.
< , J., Grosshennig, A., Braund, P. S., König, I.R., Hengstenberg, C., Hall, A. S., Linsel‐Nitschke, P., Kathiresan, S., Wright, B., Trégouët, D. A., Cambien, F., Bruse, P., Aherrahrou, Z., Wagner, A. K., Stark, K., Schwartz, S. M., Salomaa, V., Elosua, R., Melander, O., Voight, B. F., O‘Donnell, C. J., Peltonen, L., Siscovick, D. S., Altshuler, D., Merlini, P. A., Peyvandi, F., Bernardinelli, L., Ardissino, D., Schillert, A., Blankenberg, S., Zeller, T., Wild, P., Schwarz, D. F., Tiret, L., Perret, C., Schreiber, S., El Mokhtari, N. E., Schäfer, A., März, W., Renner, W., Bugert, P., Klüter, H., Schrezenmeir, J., Rubin, D., Ball, S. G., Balmforth, A. J., Wichmann, H. E., Meitinger, T., Fischer, M., Meisinger, C., Baumert, J., Peters, A., Ouwehand, W. H.; Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics Consortium, Deloukas, P., Thompson, J. R., Ziegler, A., Samani, N. J., Schunkert, H. (https://doi.org/10.1038/ng.307>
5. 2011) Association of genetic variants and incident coronary heart disease in multiethnic cohorts: The PAGE Study. Circ. Cardiovasc. Genet. 4, 661-672.
< , N., Carty, C., Buzková, P., Reiner, A. P., Garrett, T., Lin, Y., Vöckler, J. S., Hindorff, L. A., Cole, S. A., Boerwinkle, E., Lin, D. Y., Bookman, E., Best, L. G., Bella, J. N., Eaton, C., Greenland, P., Jenny, N., North, K. E., Taverna, D., Young, A. M., Deelman, E., Kooperberg, C., Psaty, B., Heiss, G. (https://doi.org/10.1161/CIRCGENETICS.111.960096>
6. 2011) Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease. Circ. Cardiovasc. Genet. 4, 169-178.
< , Y., Beitelshees, A. L., Cooper‐DeHoff, R. M., Lobmeyer, M. T., Langaee, T. Y., Wu, J., Cresci, S., Province, M. A., Spertus, J. A., Pepine, C. J., Johnson, J. A. (https://doi.org/10.1161/CIRCGENETICS.110.959296>
7. 2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 316, 1491-1493.
< , A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson, D. F., Magnusson, K. P., Andersen, K., Levey, A. I., Backman, V. M., Matthiasdottir, S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A., Vaccarino, V., Hooper, W. C., Reilly, M. P., Granger, C. B., Austin, H., Rader, D. J., Shah, S. H., Quyyumi, A. A., Gulcher, J. R., Thorgeirsson, G., Thorsteinsdottir, U., Kong, A., Stefansson, K. (https://doi.org/10.1126/science.1142842>
8. 2009) Apolipoprotein A5 in health and disease. Physiol. Res. 58 (Suppl 2), S101-S109.
< , J. A., Adámková, V., Vrablík, M., Kadlecová, M., Zicha, J., Kuneš, J., Piťha, J., Suchánek, P., Poledne, R. (https://doi.org/10.33549/physiolres.931911>
9. 2010a) A FTO variant and risk of acute coronary syndrome. Clin. Chim. Acta 411, 1069-1072.
< , J. A., Staněk, V., Gebauerová, M., Pilipčincová, A., Dlouhá, D., Poledne, R., Aschermann, M., Skalická, H., Matoušková, J., Kruger, A., Pěnička, M., Hrabáková, H., Veselka, J., Hájek, P., Lánská, V., Adámková, V., Piťha, J. (https://doi.org/10.1016/j.cca.2010.03.037>
10. 2010b) Lack of an association between connexin-37, stromelysin‐1, plasminogen activator‐inhibitor type 1 and lymphotoxin-α genes and acute coronary syndrome in Czech Caucasians. Exp. Clin. Cardiol. 15, e52-e56.
, J. A., Staněk, V., Gebauerová, M., Pilipčincová, A., Poledne, R., Aschermann, M., Skalická, H., Matoušková, J., Kruger, A., Pěnička, M., Hrabáková, H., Veselka, J., Hájek, P., Lánská, V., Adámková, V., Pit’ha, J. (
11. 2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol. 29, 1671-1677.
< , O., Stewart, A. F., Roberts, R., Wells, G., Lau, P., Naing, T., Buerki, C., McLean, B. W., Cook, R. C., Parker, J. S., McPherson, R. (https://doi.org/10.1161/ATVBAHA.109.189522>
12. 2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491.
< , R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg‐Hansen, A., Folsom, A. R., Boerwinkle, E., Hobbs, H. H., Cohen, J. C. (https://doi.org/10.1126/science.1142447>
13. 1988) A simple salting out procedure for DNA extraction from human nucleated cells. Nucl. Acids Res. 16, 1215.
< , S. A., Dykes, D. D., Polesky, H. F. (https://doi.org/10.1093/nar/16.3.1215>
14. 2010) Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease. Circ. Cardiovasc. Genet. 3, 445-453.
< , K., Post, W. S., Herzog, W., Shen, H., O‘Connell, J. R., McArdle, P. F., Ryan, K. A., Gibson, Q., Cheng, Y. C., Clearfield, E., Johnson, A. D., Tofler, G., Yang, Q., O‘Donnell, C. J., Becker, D. M., Yanek, L. R., Becker, L. C., Faraday, N., Bielak, L. F., Peyser, P. A., Shuldiner, A. R., Mitchell, B. D. (https://doi.org/10.1161/CIRCGENETICS.109.923508>
15. 2010) Association between 9p21 genomic markers and heart disease: a meta- analysis. JAMA 303, 648-656.
< , G. E., Melillo, S., Bradley, L. A. (https://doi.org/10.1001/jama.2010.118>
16. 2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448.
< , E., Sabbagh, A., Vidaud, M., Bièche, I. (https://doi.org/10.1096/fj.10-172452>
17. 2007) Genetic determination of the prognosis in survivors of the acute coronary syndromes. Study design and rationale for a multicenter study. Cor Vasa 49, 134-137.
< , J., Hubacek, J. A., Poledne, R., Stanek, V., Aschermann, M., Gebauerova, M., Hajek, P., Niederle, P., Penicka, M., Veselka, J. (https://doi.org/10.33678/cor.2007.051>
18. 2010) Why we are not able to find the coronary heart disease gene – apoE as an example. Folia Biol. (Praha) 56, 218-222.
, R., Hubáček, J. A., Staněk, V., Aschermann, M., Matoušková, J., Veselka, J., Widimský, P., Cífková, R., Lánská, V., Piťha, J. (
19. 2010) ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol. Rep. 24, 707-701.
, K., Nakagawa, H., Tajima, A., Yoshida, K., Inoue, I. (
20. 2008) Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle‐aged men. Clin. Chem. 54, 467-474.
< , P. J., Cooper, J. A., Palmen, J., Lovering, R., Drenos, F., Hingorani, A. D., Humphries, S. E. (https://doi.org/10.1373/clinchem.2007.095489>
21. Tunstall‐Pedoe, H., Kuulasmaa, K., Tolonen, H., Davidson, M., Mendis, S. (2003) MONICA Monograph and Multimedia Sourcebook. Ed. Tunstal‐Pedoe H., Geneva, World Health Organisation.